Mayfair Gold Announces LIFE Offering of Up To $35 Million
aTyr PharmaaTyr Pharma(US:LIFE) Newsfile·2025-09-08 20:12

Core Viewpoint - Mayfair Gold Corp. has announced a private placement offering of up to 21,213,000 common shares at a price of $1.65 per share, aiming to raise gross proceeds of up to $35,001,450 for its Fenn-Gib gold project and general corporate purposes [1][3]. Group 1: Offering Details - The offering will be conducted by Beacon Securities Limited as the lead agent and sole bookrunner, along with a syndicate of agents [1]. - An additional option allows the agents to sell up to 3,031,000 common shares for further gross proceeds of up to $5,001,150 [2]. - The expected closing date for the offering is around September 16, 2025, pending necessary regulatory approvals [6]. Group 2: Use of Proceeds - The net proceeds from the offering will be allocated for metallurgical and detailed engineering at the Fenn-Gib gold project, as well as for working capital and general corporate purposes [3]. Group 3: Regulatory Compliance - The common shares will be offered under the Listed Issuer Financing Exemption, allowing sales to purchasers in Canadian provinces, excluding Quebec [4]. - The offering document is available on SEDAR+ and the company's website for prospective investors [5]. Group 4: Company Overview - Mayfair Gold is focused on advancing the Fenn-Gib gold project in Timmins, Ontario, which has a total indicated resource of 181.3 million tonnes containing 4.3 million ounces of gold at a grade of 0.74 g/t [8].